Search results for "Sclerosing"

showing 10 items of 69 documents

IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine.

2016

BACKGROUND: IgG4-related disease is a rare, clinical and pathologic disease entity of unknown etiology. Its main features are increased serum concentrations of IgG4 > 1,35 g/l, lymphocyte and IgG4+plasma-cell infiltration within tissues, fibrosis or sclerosis. The classical presentation of IgG4-RSD is pancreatitis which is combined with the involvement of biliary ducts in 74 percent of patients. Extrapancreatic manifestations include: abdominal or mediastinal lymphadenopathy; the involvement of salivary glands and lacrimal glands, kidneys, lung, retroperitoneum. Since IgG4-related disease is a multiorgan lymphoproliferative syndrome, it requires a careful differential diagnosis from othe…

MaleSystemic diseasePathologymedicine.medical_specialtySettore MED/09 - Medicina InternaCholangitis SclerosingLymphadenopathyAzathioprineRetroperitoneal fibrosisSialadenitisIgG4 syndrome Internal MedicineDrug DiscoveryInternal MedicinemedicineHumansEosinophiliaAgedPharmacologybusiness.industryRetroperitoneal FibrosisSyndromemedicine.diseaseImmunoglobulin GPancreatitisIgG4-related diseaseSarcoidosismedicine.symptomDifferential diagnosisbusinessmedicine.drug
researchProduct

Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.

2006

Immunosuppression is currently the treatment of choice for severe inflammatory bowel disease (IBD). Thus, it was anticipated that the course of preexisting IBD should improve after orthotopic liver transplantation (OLT). Despite sufficient allograft immunosuppressive therapy, however, exacerbation of IBD or the development of de novo IBD after OLT were described in some cases, primarily in patients transplanted for end-stage primary sclerosing cholangitis (PSC). In addition, the development of de novo IBD in patients undergoing OLT for indications other than PSC was described. Evaluating our collective of 314 liver transplanted patients we found five patients transplanted for various indica…

Malemedicine.medical_specialtyAdolescentmedicine.medical_treatmentBiopsyAutoimmune hepatitisLiver transplantationGastroenterologyInflammatory bowel diseasePrimary sclerosing cholangitisInternal medicinemedicineHumansImmunosuppression TherapyHepatologybusiness.industryGastroenterologyImmunosuppressionHepatitis BMiddle Agedmedicine.diseaseUlcerative colitisdigestive system diseasesTacrolimusLiver Transplantationsurgical procedures operativeColitis UlcerativeFemalebusinessThe American journal of gastroenterology
researchProduct

Effect of different doses of ursodeoxycholic acid in chronic liver disease

1989

Recent clinical studies have indicated that ursodeoxycholic acid (ursodiol), administered at dosages ranging between 10 and 15 mg/kg/day, improves liver function indices in both cholestatic and inflammatory chronic liver diseases. These dosages would be considered high for the use of ursodiol in gallstone dissolution therapy. To investigate the dose-response relationship to ursodiol administration, we planned a few studies in patients with primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and chronic hepatitis (CH). Patients with PBC were subdivided into two groups on the basis of their serum bilirubin values, with 2 mg/dl as the dividing line. Ursodiol was given at dos…

Malemedicine.medical_specialtyTime FactorsPhysiologyBilirubinCholangitis SclerosingChronic liver diseaseGastroenterologyPrimary sclerosing cholangitisRandom Allocationchemistry.chemical_compoundPrimary biliary cirrhosisLiver Function TestsInternal medicinemedicineBileHumansHepatitis ChronicHepatitisDose-Response Relationship Drugmedicine.diagnostic_testLiver Cirrhosis Biliarybusiness.industryUrsodeoxycholic AcidGastroenterologyBilirubinMiddle AgedLipid Metabolismmedicine.diseaseUrsodeoxycholic acidchemistryFemaleLiver functionLiver function testsbusinessDeoxycholic Acidmedicine.drugDigestive Diseases and Sciences
researchProduct

What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?

2020

Background This study compared three different concentrations of EO (1.25%, 2.5% and 5%) for the treatment of oral vascular anomalies (OVAs). Material and Methods This was a retrospective comparative analysis of patients with OVAs treated with EO. Anomalies smaller than 20 mm were included. The patients were treated with 1.25% (G1), 2.5% (G2), and 5% (G3) and clinical data were obtained. The number of sessions, the final volume and dose of EO were statistically analyzed to verify effectiveness and safety of the treatment. The different concentrations of EO were compared considering the number of sessions, the final volume and total dose of EO. Analysis of covariance (ANCOVA) was used to eva…

Malemedicine.medical_specialtymedicine.medical_treatmentTreatment outcomeUrologyOleic Acids03 medical and health sciences0302 clinical medicineSclerotherapySclerotherapyHumansMedicineEthanolamine OleateGeneral DentistryRetrospective StudiesOral Medicine and Pathologybusiness.industryResearchRetrospective cohort study030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Sclerosing SolutionsTreatment OutcomeOtorhinolaryngologyTotal doseUNESCO::CIENCIAS MÉDICASFemaleSurgerybusiness
researchProduct

Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis

2010

Background: TGR5, the G protein-coupled bile acid receptor 1 (GPBAR1), has been linked to inflammatory pathways as well as bile homeostasis, and could therefore be involved in primary sclerosing cholangitis (PSC) a chronic inflammatory bile duct disease. We aimed to extensively investigate TGR5 sequence variation in PSC, as well as functionally characterize detected variants.Methodology/Principal Findings: Complete resequencing of TGR5 was performed in 267 PSC patients and 274 healthy controls. Six nonsynonymous mutations were identified in addition to 16 other novel single-nucleotide polymorphisms. To investigate the impact from the nonsynonymous variants on TGR5, we created a receptor mod…

Nonsynonymous substitutionMaleModels MolecularCandidate geneLinkage disequilibriumProtein ConformationDNA Mutational Analysislcsh:MedicineGenome-wide association studySUSCEPTIBILITYMULTIPLE SEQUENCE ALIGNMENTSReceptors G-Protein-CoupledMice0302 clinical medicineChildlcsh:ScienceGenetics and Genomics/Genetics of DiseaseGENE-EXPRESSIONGenetics0303 health sciencesMultidisciplinaryGastroenterology and Hepatology/Biliary TractCROHN-DISEASEMiddle AgedG protein-coupled bile acid receptor3. Good healthGenetics and Genomics/Gene FunctionULCERATIVE-COLITISChromosomes Human Pair 2WEB SERVER030211 gastroenterology & hepatologyFemaleResearch ArticleAdultAdolescentCholangitis SclerosingSingle-nucleotide polymorphismLocus (genetics)BiologyGenetics and Genomics/Complex TraitsPrimary sclerosing cholangitis03 medical and health sciencesYoung AdultDogsPROTEIN-COUPLED RECEPTORSLIVER-DISEASEmedicineAnimalsHumansAmino Acid SequenceBOWEL-DISEASE030304 developmental biologyAgedGastroenterology and Hepatology/Inflammatory Bowel DiseaseCYSTIC-FIBROSISlcsh:Rmedicine.diseaseGene Expression RegulationMutationCancer researchCattleColitis Ulcerativelcsh:Q
researchProduct

Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.

2021

International audience; Background: After liver transplantation (LT),de novo malignancies are one of the leading causes of late mortality. The aim of the present retrospective study was to identify the risk factors of de novo malignancies in a large cohort of LT recipients in France, using Fine and Gray competing risks regression analysis.Methods: The study population consisted in 11004 adults transplanted between 2000 and 2013, who had no history of pre-transplant malignancy, except primary liver tumor. A Cox model adapted to the identification of prognostic factors (competitive risks) was used.Results: From the entire cohort, one (or more)de novo malignancy was reported in 1480 L T recipi…

OncologyAdultMalemedicine.medical_specialtyMESH: Liver TransplantationLiver tumormedicine.medical_treatmentLiver transplantationMalignancyPrimary sclerosing cholangitis03 medical and health sciencesLiver disease0302 clinical medicineMESH: Liver NeoplasmsMESH: Risk FactorsRisk FactorsInternal medicinemedicineHumansMESH: IncidenceLung cancerRetrospective StudiesMESH: HumansHepatologybusiness.industryIncidenceLiver NeoplasmsGastroenterologyRetrospective cohort studyMESH: AdultMESH: Retrospective Studies[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyCompeting riskmedicine.disease[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMESH: MaleLiver Transplantation030220 oncology & carcinogenesisPopulation study030211 gastroenterology & hepatologybusinessLiver transplantationde novomalignanciesClinics and research in hepatology and gastroenterology
researchProduct

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

2014

Pathologymedicine.medical_specialtyGlobal HealthPractice guidelinesPrimary sclerosing cholangitisCholangiocarcinomamedicineHumansIntrahepatic CholangiocarcinomaIntrahepatic cholangiocarcinomaEvidence-Based MedicineBiliary tract cancerHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyRecurrent Intrahepatic Cholangiocarcinomamedicine.diseaseBile Ducts IntrahepaticDiagnosis and managementBile Duct NeoplasmsPositron emission tomographyPractice Guidelines as TopicbusinessComparative genomic hybridizationContrast-enhanced ultrasoundJournal of Hepatology
researchProduct

Magnetic resonance imaging in infections of the brain: findings in tuberculosis, listeriosis, toxoplasmosis, subacute sclerosing panencephalitis, and…

1987

A total of 6 patients with various inflammatory brain diseases were investigated by MRI. Typical diagnostic criteria like signal intensity, location, and morphology of the lesions are presented. MRI proves to be a highly sensitive method to detect encephalitic foci, which, however, suffers from a low specificity. Therefore additional informations like case history, clinical findings, and serological data have to be considered to find the correct diagnosis.

Pathologymedicine.medical_specialtyTuberculosisMultiple SclerosisSubacute sclerosing panencephalitisSerologymedicineHumansTuberculosisListeriosisChildBrain Diseasesmedicine.diagnostic_testbusiness.industryMultiple sclerosisBrainMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingToxoplasmosisSurgeryNeurology (clinical)NeurosurgerySubacute Sclerosing PanencephalitisbusinessEncephalitisNeurosurgical review
researchProduct

Le pneumocytome sclérosant : une tumeur rare et apparemment bénigne

2020

International audience; Introduction: Sclerosing pneumocytoma is a benign and rare lung tumor affecting epithelial cells. In most cases, patients are asymptomatic and the diagnosis is made on an X ray or a CT scan performed for other enquiry. Sex ratio favors women. Epidemiological studies report that middle-aged Asian women are more frequently affected. Radiological investigations find a solitary nodule or a mass with peripheric localization. When performed, histological analysis shows a tumor composed of at least two of the four following architectures: papillary, sclerosing, hemangiomatous and solid, with two types of cells that can be round or cubic cells.Cases report: We report two cas…

Pulmonary and Respiratory MedicineGynecologymedicine.medical_specialtybusiness.industryRare tumor[SDV]Life Sciences [q-bio]Sclerosing pneumocytomaBenign tumormedicine.diseaseSclerosing pneumocytoma030218 nuclear medicine & medical imagingBenign tumor[SDV] Life Sciences [q-bio]03 medical and health sciencesRare tumorLung nodules0302 clinical medicine030220 oncology & carcinogenesisSclerosing hemangiomamedicinebusiness
researchProduct

Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis

1998

SUMMARY Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology. Recent studies have shown that genetic factors and both cellular and humoral immunological abnormalities are important in the pathogenesis of PSC. The most prominent autoantibodies in PSC are anti-neutrophil cytoplasmic antibodies (ANCA). The autoepitopes of ANCA in PSC are not well defined. The aim of this study was to identify corresponding ANCA autoantigens in patients with PSC. A biochemical approach with enrichment and partial purification of soluble neutrophil proteins, detection of autoantibodies by Western blot and partial amino acid sequencing were used. Two new autoantigen/aut…

endocrine system diseasesAlpha-enolaseBlotting WesternCholangitis SclerosingMolecular Sequence DataImmunologyAutoimmunityEnzyme-Linked Immunosorbent Assaymedicine.disease_causedigestive systemAutoimmunityPrimary sclerosing cholangitisAntigenWestern blotmedicineHumansImmunology and AllergyAmino Acid SequenceAutoantibodiesAnti-neutrophil cytoplasmic antibodybiologymedicine.diagnostic_testdigestive oral and skin physiologyAutoantibodyOriginal ArticlesCatalasemedicine.diseasedigestive system diseasesPhosphopyruvate HydrataseImmunologybiology.proteinAntibodyClinical and Experimental Immunology
researchProduct